United States Healthcare Equipment & Supplies

Catheter Precision Inc (VTAK)

Track

Catheter Precision Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in January 2024, when Executive Chairman and CEO David A. Jenkins executed multiple share purchases. Prior to these acquisitions, historical records indicate various buying and selling patterns by company leadership dating back to 2020.
Ticker: VTAK Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Catheter Precision Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
JENKINS DAVID A Executive Chairman and CEO Executive Director
Transaction date
Purchase
Price
62.22
Quantity 29,303 +7.4%
Value US$825,985
2.5
JENKINS DAVID A Executive Chairman and CEO Executive Director
Transaction date
Purchase
Price
51.91
Quantity 15,857 +27.0%
Value US$4,528,071
2.5
JENKINS DAVID A Executive Chairman and CEO Executive Director
Transaction date
Purchase
Price
444.80
Quantity 38,362 +24.3%
Value US$3,408,862
2.5
JENKINS DAVID A Executive Chairman and CEO Executive Director
Transaction date
Purchase
Price
0.41
Quantity 8,470 +2.9%
Value US$3,491
2.5
JENKINS DAVID A Executive Chairman and CEO Executive Director
Transaction date
Purchase
Price
0.39
Quantity 8,470 +3.0%
Value US$3,313
2.5
JENKINS DAVID A Executive Chairman and CEO Executive Director
Transaction date
Purchase
Price
0.39
Quantity 7,793 +2.8%
Value US$3,010
2.2
Jackson Andrew C. CFO Officer
Transaction date
Sale
Price
2.62
Quantity 2,684 -10.4%
Value US$7,032
2.4
McGuire Jonathan Will Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.62
Quantity 8,149 -10.9%
Value US$21,350
2.9
ENQUIST WILLIAM R Non-Executive Director
Transaction date
Purchase
Price
5.82
Quantity 5,263 +inf%
Value US$30,622
1.3
Mejia Richard Jr Non-Executive Director
Transaction date
Purchase
Price
5.82
Quantity 1,000 +13.3%
Value US$5,820
3.2
COLOMBATTO MARTIN J Non-Executive Director
Transaction date
Purchase
Price
5.78
Quantity 8,700 +129.1%
Value US$50,279
3.2
Stafslien Joan Non-Executive Director
Transaction date
Purchase
Price
5.67
Quantity 4,410 +inf%
Value US$25,002
2.4
McGuire Jonathan Will Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.35
Quantity 10,000 +7.4%
Value US$3,500
3.5
Kraws Jeffrey J Co-President Officer
Transaction date
Purchase
Price
0.35
Quantity 10,000 +8.1%
Value US$3,500
1.5
Horwood Daniel General Counsel Officer
Transaction date
Purchase
Price
0.35
Quantity 10,000 +23.5%
Value US$3,500
2.2
Jackson Andrew C. CFO Officer
Transaction date
Purchase
Price
0.35
Quantity 10,000 +24.9%
Value US$3,500
1.3
Mejia Richard Jr Non-Executive Director
Transaction date
Purchase
Price
0.60
Quantity 50,000 +131.3%
Value US$29,915
2.9
ENQUIST WILLIAM R Non-Executive Director
Transaction date
Purchase
Price
0.47
Quantity 50,000 +131.3%
Value US$23,700
3.5
Kraws Jeffrey J Co-President Officer
Transaction date
Purchase
Price
0.46
Quantity 10,000 +8.8%
Value US$4,600
2.4
McGuire Jonathan Will Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.46
Quantity 10,000 +8.0%
Value US$4,648
2.2
Jackson Andrew C. CFO Officer
Transaction date
Purchase
Price
0.46
Quantity 10,000 +33.1%
Value US$4,648
1.5
Horwood Daniel General Counsel Officer
Transaction date
Purchase
Price
0.47
Quantity 10,000 +30.6%
Value US$4,650
3.9
Irwin Dean Large shareholder
Transaction date
Sale
Price
1.07
Quantity 60,000 -2.1%
Value US$64,014
3.9
Irwin Dean Large shareholder
Transaction date
Planned sale
Price
1.03
Quantity 26,400 -47.9%
Value US$27,181
3.9
Irwin Dean Large shareholder
Transaction date
Planned sale
Price
1.03
Quantity 44,400 -66.2%
Value US$45,621
3.9
Irwin Dean Large shareholder
Transaction date
Planned sale
Price
1.89
Quantity 7,700 -12.3%
Value US$14,569
3.9
Irwin Dean Large shareholder
Transaction date
Planned sale
Price
1.89
Quantity 12,950 -16.2%
Value US$24,499
Burstein Martin Large shareholder
Transaction date
Sale
Price
0.75
Quantity 4,448 -0.3%
Value US$3,336
Burstein Martin Large shareholder
Transaction date
Sale
Price
0.75
Quantity 22,436 -1.4%
Value US$16,827
Burstein Martin Large shareholder
Transaction date
Sale
Price
0.84
Quantity 20,000 -1.2%
Value US$16,800
Burstein Martin Large shareholder
Transaction date
Sale
Price
0.87
Quantity 6,100 -0.4%
Value US$5,307
Burstein Martin Large shareholder
Transaction date
Sale
Price
1.01
Quantity 46,820 -2.7%
Value US$47,288
Burstein Martin Large shareholder
Transaction date
Sale
Price
1.06
Quantity 28,988 -1.7%
Value US$30,727
Burstein Martin Large shareholder
Transaction date
Sale
Price
1.27
Quantity 1,208 -0.1%
Value US$1,534
3.9
Irwin Dean Large shareholder
Transaction date
Planned sale
Price
1.19
Quantity 4,400 -5.3%
Value US$5,215
3.9
Irwin Dean Large shareholder
Transaction date
Planned sale
Price
1.19
Quantity 7,400 -7.4%
Value US$8,786
3.5
Kraws Jeffrey J Co-President
Transaction date
Sale
Price
2.93
Quantity 11,930 -7.3%
Value US$34,972
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
2.93
Quantity 8,584 -6.7%
Value US$25,163
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
2.93
Quantity 14,302 -6.7%
Value US$41,925
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Planned sale
Price
3.28
Quantity 4,400 -3.3%
Value US$14,413
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Planned sale
Price
3.27
Quantity 7,400 -3.3%
Value US$24,172
2.2
Jackson Andrew C. CFO
Transaction date
Sale
Price
3.08
Quantity 5,134 -13.0%
Value US$15,794
3.5
Kraws Jeffrey J Co-President
Transaction date
Sale
Price
3.08
Quantity 18,021 -9.9%
Value US$55,438
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
3.82
Quantity 8,246 -5.8%
Value US$31,500
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
3.82
Quantity 13,736 -5.8%
Value US$52,472
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
3.49
Quantity 7,776 -5.2%
Value US$27,138
3.9
Irwin Dean See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
3.49
Quantity 13,152 -5.3%
Value US$45,900
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-24 2024-01-23 B Purchase
2.5
JENKINS DAVID A

Executive Chairman and CEO

Executive Director
29,303 +7.4%
62.22
US$825,985 		29,303 +7.4% 62.22 US$825,985
2024-01-24 2024-01-22 B Purchase
2.5
JENKINS DAVID A

Executive Chairman and CEO

Executive Director
15,857 +27.0%
51.91
US$4,528,071 		15,857 +27.0% 51.91 US$4,528,071
2024-01-22 2024-01-19 B Purchase
2.5
JENKINS DAVID A

Executive Chairman and CEO

Executive Director
38,362 +24.3%
444.80
US$3,408,862 		38,362 +24.3% 444.80 US$3,408,862
2024-01-22 2024-01-18 B Purchase
2.5
JENKINS DAVID A

Executive Chairman and CEO

Executive Director
8,470 +2.9%
0.41
US$3,491 		8,470 +2.9% 0.41 US$3,491
2024-01-18 2024-01-16 B Purchase
2.5
JENKINS DAVID A

Executive Chairman and CEO

Executive Director
8,470 +3.0%
0.39
US$3,313 		8,470 +3.0% 0.39 US$3,313
2024-01-18 2024-01-16 B Purchase
2.5
JENKINS DAVID A

Executive Chairman and CEO

Executive Director
7,793 +2.8%
0.39
US$3,010 		7,793 +2.8% 0.39 US$3,010
2021-11-24 2021-11-22 S Sale
2.2
Jackson Andrew C.

CFO

Officer
2,684 -10.4%
2.62
US$7,032 		2,684 -10.4% 2.62 US$7,032
2021-11-24 2021-11-22 S Sale
2.4
McGuire Jonathan Will

Chief Executive Officer

Executive Director
8,149 -10.9%
2.62
US$21,350 		8,149 -10.9% 2.62 US$21,350
2020-11-23 2020-11-19 B Purchase
2.9
ENQUIST WILLIAM R
Non-Executive Director
5,263 +inf%
5.82
US$30,622 		5,263 +inf% 5.82 US$30,622
2020-11-23 2020-11-19 B Purchase
1.3
Mejia Richard Jr
Non-Executive Director
1,000 +13.3%
5.82
US$5,820 		1,000 +13.3% 5.82 US$5,820
2020-11-19 2020-11-19 B Purchase
3.2
COLOMBATTO MARTIN J
Non-Executive Director
8,700 +129.1%
5.78
US$50,279 		8,700 +129.1% 5.78 US$50,279
2020-11-19 2020-11-19 B Purchase
3.2
Stafslien Joan
Non-Executive Director
4,410 +inf%
5.67
US$25,002 		4,410 +inf% 5.67 US$25,002
2020-08-05 2020-08-03 B Purchase
2.4
McGuire Jonathan Will

Chief Executive Officer

Executive Director
10,000 +7.4%
0.35
US$3,500 		10,000 +7.4% 0.35 US$3,500
2020-08-05 2020-08-03 B Purchase
3.5
Kraws Jeffrey J

Co-President

Officer
10,000 +8.1%
0.35
US$3,500 		10,000 +8.1% 0.35 US$3,500
2020-08-05 2020-08-03 B Purchase
1.5
Horwood Daniel

General Counsel

Officer
10,000 +23.5%
0.35
US$3,500 		10,000 +23.5% 0.35 US$3,500
2020-08-05 2020-08-03 B Purchase
2.2
Jackson Andrew C.

CFO

Officer
10,000 +24.9%
0.35
US$3,500 		10,000 +24.9% 0.35 US$3,500
2020-06-15 2020-06-12 B Purchase
1.3
Mejia Richard Jr
Non-Executive Director
50,000 +131.3%
0.60
US$29,915 		50,000 +131.3% 0.60 US$29,915
2020-06-01 2020-05-29 B Purchase
2.9
ENQUIST WILLIAM R
Non-Executive Director
50,000 +131.3%
0.47
US$23,700 		50,000 +131.3% 0.47 US$23,700
2020-05-27 2020-05-22 B Purchase
3.5
Kraws Jeffrey J

Co-President

Officer
10,000 +8.8%
0.46
US$4,600 		10,000 +8.8% 0.46 US$4,600
2020-05-27 2020-05-22 B Purchase
2.4
McGuire Jonathan Will

Chief Executive Officer

Executive Director
10,000 +8.0%
0.46
US$4,648 		10,000 +8.0% 0.46 US$4,648
2020-05-27 2020-05-22 B Purchase
2.2
Jackson Andrew C.

CFO

Officer
10,000 +33.1%
0.46
US$4,648 		10,000 +33.1% 0.46 US$4,648
2020-05-27 2020-05-22 B Purchase
1.5
Horwood Daniel

General Counsel

Officer
10,000 +30.6%
0.47
US$4,650 		10,000 +30.6% 0.47 US$4,650
2020-04-29 2020-04-28 S Sale
3.9
Irwin Dean
Large shareholder
60,000 -2.1%
1.07
US$64,014 		60,000 -2.1% 1.07 US$64,014
2020-04-29 2020-04-27 PlS Planned sale
3.9
Irwin Dean
Large shareholder
26,400 -47.9%
1.03
US$27,181 		26,400 -47.9% 1.03 US$27,181
2020-04-29 2020-04-27 PlS Planned sale
3.9
Irwin Dean
Large shareholder
44,400 -66.2%
1.03
US$45,621 		44,400 -66.2% 1.03 US$45,621
2020-01-24 2020-01-22 PlS Planned sale
3.9
Irwin Dean
Large shareholder
7,700 -12.3%
1.89
US$14,569 		7,700 -12.3% 1.89 US$14,569
2020-01-24 2020-01-22 PlS Planned sale
3.9
Irwin Dean
Large shareholder
12,950 -16.2%
1.89
US$24,499 		12,950 -16.2% 1.89 US$24,499
2019-12-18 2019-12-17 S Sale Burstein Martin Large shareholder
4,448 -0.3%
0.75
US$3,336 		4,448 -0.3% 0.75 US$3,336
2019-12-18 2019-12-16 S Sale Burstein Martin Large shareholder
22,436 -1.4%
0.75
US$16,827 		22,436 -1.4% 0.75 US$16,827
2019-12-16 2019-12-13 S Sale Burstein Martin Large shareholder
20,000 -1.2%
0.84
US$16,800 		20,000 -1.2% 0.84 US$16,800
2019-12-16 2019-12-12 S Sale Burstein Martin Large shareholder
6,100 -0.4%
0.87
US$5,307 		6,100 -0.4% 0.87 US$5,307
2019-12-10 2019-12-10 S Sale Burstein Martin Large shareholder
46,820 -2.7%
1.01
US$47,288 		46,820 -2.7% 1.01 US$47,288
2019-12-10 2019-12-09 S Sale Burstein Martin Large shareholder
28,988 -1.7%
1.06
US$30,727 		28,988 -1.7% 1.06 US$30,727
2019-12-10 2019-12-06 S Sale Burstein Martin Large shareholder
1,208 -0.1%
1.27
US$1,534 		1,208 -0.1% 1.27 US$1,534
2020-01-24 2019-12-04 PlS Planned sale
3.9
Irwin Dean
Large shareholder
4,400 -5.3%
1.19
US$5,215 		4,400 -5.3% 1.19 US$5,215
2020-01-24 2019-12-04 PlS Planned sale
3.9
Irwin Dean
Large shareholder
7,400 -7.4%
1.19
US$8,786 		7,400 -7.4% 1.19 US$8,786
2019-07-23 2019-07-18 S Sale
3.5
Kraws Jeffrey J

Co-President
11,930 -7.3%
2.93
US$34,972 		11,930 -7.3% 2.93 US$34,972
2019-07-22 2019-07-18 S Sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
8,584 -6.7%
2.93
US$25,163 		8,584 -6.7% 2.93 US$25,163
2019-07-22 2019-07-18 S Sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
14,302 -6.7%
2.93
US$41,925 		14,302 -6.7% 2.93 US$41,925
2019-07-16 2019-07-12 PlS Planned sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
4,400 -3.3%
3.28
US$14,413 		4,400 -3.3% 3.28 US$14,413
2019-07-16 2019-07-12 PlS Planned sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
7,400 -3.3%
3.27
US$24,172 		7,400 -3.3% 3.27 US$24,172
2019-06-17 2019-06-13 S Sale
2.2
Jackson Andrew C.

CFO
5,134 -13.0%
3.08
US$15,794 		5,134 -13.0% 3.08 US$15,794
2019-06-17 2019-06-13 S Sale
3.5
Kraws Jeffrey J

Co-President
18,021 -9.9%
3.08
US$55,438 		18,021 -9.9% 3.08 US$55,438
2019-05-14 2019-05-13 S Sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
8,246 -5.8%
3.82
US$31,500 		8,246 -5.8% 3.82 US$31,500
2019-05-14 2019-05-13 S Sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
13,736 -5.8%
3.82
US$52,472 		13,736 -5.8% 3.82 US$52,472
2019-04-15 2019-04-11 S Sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
7,776 -5.2%
3.49
US$27,138 		7,776 -5.2% 3.49 US$27,138
2019-04-15 2019-04-11 S Sale
3.9
Irwin Dean

See Remarks

Executive Director Large shareholder
13,152 -5.3%
3.49
US$45,900 		13,152 -5.3% 3.49 US$45,900
Explore more

More insider trading research around Catheter Precision Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America